Dacarbazine 4342-03-4

Dacarbazine (da-KAR-ba-zeen) (brand names DTIC, DTIC-Dome; also known as DIC or Imidazole Carboxamide) is an antineoplastic chemotherapy drug used in the treatment of various cancers, among them malignant melanoma, Hodgkin lymphoma, sarcoma, and islet cell carcinoma of the pancreas. Antineoplastic drugs are drugs which interfere with cell growth and impede the formation of new tissue - in this case, tumor tissue. These drugs are also known as cytotoxic drugs. Dacarbazine belongs to the family of chemicals known as alkylating agents. Dacarbazine is normally administered by injection (a shot) or intravenous infusion (IV) under the immediate supervision of a doctor or nurse.

read more [+]

Systematic (IUPAC) name:	5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
Dacarbazine CAS number:	4342-03-4
ATC code:	L01AX04
PubChem:	2942
DrugBank:	APRD00331
Formula:	C6H10N6O1
Molecular mass:	182.18 g/mol
Dacarbazine Assay/Purity:	Typically NLT 98%

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.